eli lily retatrutide Retatrutide, the next generation of GLP-1 drug from Lilly, helped participants lose an average of 71.2 pounds and reduce knee arthritis pain in a late-stage clinical trial, the company announced. In Senator asks RFK Jr. if

Nutritious products must be accessible to GLP-1 users to achieve healthy eating habits that provide essential nutrients, vitamins, and minerals

Gallbladder risk is a known tradeoff of GLP-1 therapy, and managing it well means working with a provider before and during treatment, not waiting until symptoms escalate

This blog will dive into the details of Semaglutide side effects and offer insights on how to approach treatment safely

Lillys oral GLP-1, orforglipron, demonstrated statistically significant efficacy results and a safety profile consistent with injectable GLP-1 medicines in successful Phase 3 trial | Eli Lilly and Company [Internet]